Product Images Methylphenidate Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Methylphenidate Hydrochloride NDC 62037-725 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula - image 1

Structural Formula - image 1

figure1 - image 2

figure1 - image 2

figure2 - image 3

figure2 - image 3

figure 3 - image 4

figure 3 - image 4

This appears to be a table of results from a study comparing the effects of Methylphenidate HCI extended-release tablets to a placebo on the Combined Attention Subscale. The table displays the scores at various times post-initial dose for both the group that received the medication and the group that received the placebo. The table also notes the sample size and shows the mean and standard error of the mean.*

1 - image 5

1 - image 5

This is a medication guide for Methylphenidate Hydrochloride extended release tablets. The tablets come in a bottle of 100 and contain 18 mg USP. Patients are advised to take only one tablet once daily as indicated in the package insert. The pharmacist should dispense the accompanying medication guide to each patient. The medication should be stored between 20°C and 25°C (68°F and 77°F), and protected from humidity. The package is serialized coded.*

1 - image 6

1 - image 6

This is a description for a medication containing methylphenidate hydrochloride in extended-release tablets. It's intended for once-daily use and comes with a medication guide that should be given to every patient. The typical dose should be found in the package insert. The medication should be stored between 20°C to 25°C, with permissible excursions to 15°C to 30°C. It should be protected from humidity and stored in a tight container with a child-resistant closure. This medication should be kept out of reach of children. The manufacturer is Teva Pharmaceuticals, and it contains 100 tablets. The text includes a code for serialization at the end.*

1 - image 7

1 - image 7

This is a description for Once-Daily Methylphenidate Hydrochloride Extended-Release Tablets, USP by Teva Pharmaceuticals. It is a prescription medication that comes in a container with 100 tablets. The usual dosage is once a day, and each tablet contains 36 mg of Methylphenidate hydrochloride USP (an extended-release formulation). Pharmacist is advised to dispense the medication guide to each patient. The medication should be stored at a temperature between 20°C to 25°C, with humidity protection. It must be kept out of children's reach, in a tight and light-resistant container. The description also provides the address and contact details of the manufacturer (Teva Pharmaceuticals Parsippany, NJ 07054). However, there is no information available about its usage and effects.*

1 - image 8

1 - image 8

This is a medication guide for the pharmaceutical drug Methylphenidate Hydrochloride, an extended-release medication in tablet form. It is recommended for daily use and comes in a bottle of 100 tablets. The medication should be stored within the temperature range of 20° to 25°C (68° to 77°F). Patients should be instructed to keep the medication out of the reach of children. In addition, it is the pharmacist's responsibility to provide a Medication Guide to each patient. The rest of the text contains instructions for dispensing and manufacturing information.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.